Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 2 months ago
Share
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
1090 patients around the world
Available in
Brazil
Menzies School of Health Research
1090
Patients around the world
This study is for people with
Malaria
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
TADORE
Sponsor
Menzies School of Health Research
Conditions
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06148792
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent